Thyroid Endocrine Disrupting Potential of Fluoxetine in Zebrafish Larvae
Journal of Applied Toxicology · 2025
DOI: 10.1002/jat.4755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Jin Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shengda Hydropower Co. Ltd, Power Construction Corporation of China, Leshan, China. Hauptthemen laut MEDLINE: Zebrafish, Fluoxetine, Thyroid Gland, Endocrine Disruptors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Project, National Key Research and Development Program of China.
Abstract (Originalsprache)
Fluoxetine (FLX), a typical selective serotonin reuptake inhibitors, has been frequently detected in aquatic environment and wild fish. However, little is known about its effect on thyroid endocrine system. In the present study, zebrafish ( Danio rerio ) embryos were exposed to 1, 3, 10, and 30 μg/L of FLX for 6 days. Chemical analysis demonstrated that FLX and its metabolic product (nonfluoxetine, NFLX) were accumulated in zebrafish larvae. The exposure resulted in decreased thyroid hormones (THs) levels, indicating thyroid endocrine disruption. Moreover, thyroid‐stimulating hormone (TSH) content was significantly inhibited in a concentration‐dependent manner after exposure to FLX. Gene transcription in the hypothalamic–pituitary–thyroid (HPT) axis was further examined, and the results showed that the genes encoding corticotrophin‐releasing hormone ( crh ) and thyrotropin‐releasing hormone ( trh ) were significantly up‐regulated as a compensatory mechanism for the decreased TH contents accompanied with decreased tshβ mRNA expression. In addition, genes involved in thyroid hormone synthesis (sodium/iodide symporter, nis , thyroglobulin, tg ) and transport (transthyretin, ttr ) were down‐regulated after exposure to FLX in a concentration‐dependent manner. The increased gene transcription of deiodinases ( dio2 ) and uridinediphosphate‐glucuronosyltransferase ( ugt1ab ) might be responsible for the decrease of TH contents. In addition, a significant inhibition in thyroid hormone receptors ( trα and trβ ) gene expression was observed upon treatment with FLX. All these results demonstrated that FLX could alter THs and TSH content as well as gene transcription in the HPT axis, exerting an endocrine disruption of the thyroid system in zebrafish larvae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shengda Hydropower Co. Ltd, Power Construction Corporation of China, Leshan, China.
- Monitoring Department One, Guizhou Provincial Ecological Environmental Monitoring Center, Guiyang, China.
- Changjiang Basin Ecology and Environment Monitoring and Scientific Research Center, Changjiang Basin Ecology and Environment Administration, Ministry of Ecology and Environment, Wuhan, China.
- State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.
- School of Environmental Studies, China University of Geosciences, Wuhan, China.
ORCID-Profile: Heying Sun
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Project
- National Key Research and Development Program of China
Zitieren
APA
Huang, J., Liu, K., Chen, S., Tang, H., Li, R., Wang, X., & Sun, H. (2025). Thyroid Endocrine Disrupting Potential of Fluoxetine in Zebrafish Larvae. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4755
Vancouver
Huang J, Liu K, Chen S, Tang H, Li R, Wang X, et al. Thyroid Endocrine Disrupting Potential of Fluoxetine in Zebrafish Larvae. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4755
BibTeX
@article{Huang2025,
author = {Huang, Jin and Liu, Kunyun and Chen, Shan and Tang, Huijia and Li, Ruiwen and Wang, Xianzheng and Sun, Heying},
title = {Thyroid Endocrine Disrupting Potential of Fluoxetine in Zebrafish Larvae},
journal = {Journal of Applied Toxicology},
year = {2025},
doi = {10.1002/jat.4755}
}
EUVIMED